|
⚲
|
| Keyboard |
| Monohon Ted
✚
|
|
|---|---|
| CIK # | 0001606905 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001606905] | |
| 4 | [0001606905] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Monohon Ted | |
| Quince Therapeutics Inc | |
| Fantex Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-03-06 | Sell | 1,871 | $0.98 | 1,834 |
|
Quince Therapeutics Inc QNCX
Employee Stock Option (right to buy) · derivative
|
2023-02-01 | Grant | 110,000 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2022-12-05 | Tax withheld | 1,640 | $0.72 | 1,181 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2022-09-06 | Tax withheld | 1,520 | $1.64 | 2,493 |
|
Quince Therapeutics Inc CRTX
Stock Option (right to buy) · derivative
|
2022-06-29 | Grant | 250,000 | $0.00 | |
|
Quince Therapeutics Inc CRTX
Common Stock
|
2022-06-06 | Tax withheld | 1,529 | $3.12 | 4,770 |
|
Quince Therapeutics Inc CRTX
Common Stock
|
2022-03-03 | Grant | 34,000 | $0.00 | |
|
Quince Therapeutics Inc CRTX
Stock Option (right to buy) · derivative
|
2021-12-14 | Grant | 50,000 | $0.00 | |
|
Quince Therapeutics Inc CRTX
Employee Stock Option (right to buy) · derivative
|
2021-02-09 | Grant | 20,000 | $0.00 |